ALX Oncology Holdings Inc

ALXO · NASDAQ

Research and Development in Biotechnology

ALX Oncology Holdings Inc. operates as a clinical stage immuno-oncology company. The Company focuses on helping patients fight cancer by developing therapies that bridge the innate and adaptive immune system. ALX Oncology Holdings serves patients in the State of California.

ESG Scores

Overall ESG

4.1

Environmental

7.3

Social

4.4

Governance

4.3

Gender Diversity

Female Directors0.375%

Female Executives0.15789473684210525%

CEO GenderMale

Market Data

Price$1.67-0.01 (-0.60%)

Market Cap$220M

P/E Ratio—

EPS$—

52W High$2.66

52W Low$0.40

Beta0.43